Boston Scientific Corp(BSX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 7:27 PM ET (Korea 10/24 08:27)
Full metrics table
| Index | S&P 500 | P/E | 18.53 | EPS (ttm) | 2.47 | Insider Own | 0.65% | Shs Outstand | 1.45B | Perf Week | 2.93% |
| Market Cap | 66.22B | Forward P/E | 13.53 | EPS next Y | 4.6% | Insider Trans | 2.24% | Shs Float | 1.44B | Perf Month | 2.26% |
| Enterprise Value | 78.43B | PEG | 1.97 | EPS next Q | 0.72 | Inst Own | 94.12% | Short Float | 2.88% | Perf Quarter | 0.4% |
| Income | 3.67B | P/S | 3.15 | EPS this Y | 5.54% | Inst Trans | -1.84% | Short Ratio | 2.11 | Perf Half Y | -26.39% |
| Sales | 21.00B | P/B | 2.65 | EPS next 5Y | 6.88% | ROA | 8.47% | Short Interest | 41.41M | Perf YTD | -52.08% |
| Book/sh | 17.23 | P/C | 102.18 | EPS past 3/5Y | 63.23% - | ROE | 15.52% | 52W High | -56.75% ($105.65) | Perf Year | -55.38% |
| Cash/sh | 0.45 | P/FCF | 18.27 | Sales past 3/5Y | 16.54% 15.16% | ROIC | 10.25% | 52W Low | 10.4% ($41.38) | Perf 3Y | -8.86% |
| Dividend Est. | - | EV/EBITDA | 13.09 | EPS Y/Y TTM | 46.29% | Gross Margin | 66.36% | Volatility(W/M) | 2.77% 2.61% | Perf 5Y | 1.9% |
| Dividend TTM | - | EV/Sales | 3.74 | Sales Y/Y TTM | 13.53% | Oper. Margin | 21.8% | ATR (14) | 1.26 | Perf 10Y | 100.22% |
| Dividend Ex-Date | - | Quick Ratio | 0.74 | EPS Q/Q | 15.25% | Profit Margin | 17.5% | RSI (14) | 57.22 | Recom | 1.53 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.24 | Sales Q/Q | 7.53% | SMA20 | 4.56% ($43.7) | Beta | 0.59 | Target Price | $57.93 |
| Payout | - | Debt/Eq | 0.51 | Earnings | 2026/10/28 | SMA50 | 0.33% ($45.54) | Rel Volume | 0.45 | Prev Close | $46.01 |
| Employees | 59000 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | 2.93% 1.25% | SMA200 | -20.99% ($57.83) | Avg Volume(3M) | 19.61M | Price | $45.69 |
| IPO | 1992/5/19 | Option/Short | Yes/Yes | Trades | 42226 | Volume | 8,772,775 | Change | -0.7% |
🩺 A leading company in the global medical device industry. Headquartered in Marlborough, Massachusetts, USA, this comprehensive medical device group was founded in 1979 and has been operating a diverse portfolio of minimally invasive medical devices across multiple categories, including cardiology, cardiac rhythm management, peripheral vascular, endoscopy, and urology.
Over the past 1 year, on the lower side
57% below its 1-year high.
Traded less than usual. That is 45% of its average volume.
Next earnings report: October 28
2 days to go.
BSX makes money exceptionally well
Of every $100 in sales, $21.80 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +5.5% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $1,353. Peers typically go for $1,844. Compared with its own 5-year average, it is 72% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be +1.9%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 94.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 of 143 in the industry
Based on market cap of $66B.
MDT#2 Medtronic Plc $122B PER 23.5 
SYK#3 Stryker Corp $118B PER 31.8 
BSX#4 Boston Scientific Corp $66B PER 18.5 
EW#5 Edwards Lifesciences Corp $51B PER 52.9 
GEHC#6 GE HealthCare Technologies Inc $32B PER 16.4 
FAQ
What kind of company is BSX?
BSX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of BSX?
The market cap of BSX is approximately $66.2B, ranking 254 within its sector.
What is the P/E ratio of BSX?
BSX has a P/E ratio of approximately 18.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BSX?
BSX has recorded a 52-week high of $105.65 and a low of $41.38.
